Impact of Disclosing Amyloid Imaging Results to Cognitively Normal Individuals
Impact of Disclosing Amyloid Imaging Results to Cognitively Normal Individuals
批准号:
9518218
负责人:
Robert C. Green
金额:
$11.45万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-20 至 2019-06-30
关键词:
AddressAfrican AmericanAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloidApolipoproteinsBehavioralBiological MarkersBrainBrain PathologyBrain imagingClinical InvestigatorClinical TrialsCognitiveCommunicationComplexDataDementiaDisclosureDiseaseEnrollmentEthnic groupEventFundingFutureGenotypeGoalsHealth PlanningHealth behaviorImpaired cognitionIndividualKnowledgeLearningLong-Term Care InsuranceMeasuresMemoryMinorityNeuropsychologyOutcomeOutcome MeasureParticipantPerformancePersonsPopulation HeterogeneityPositron-Emission TomographyPrevention trialProcessProtocols documentationPsychological ImpactQuality of lifeRaceRandomizedRandomized Clinical TrialsReadingRecruitment ActivityResearch PersonnelRiskSafetySamplingScanningSiteStereotypingSuggestionSymptomsTest ResultTestingTimeTranslationsUnited States National Institutes of HealthWorkagedamyloid imagingbehavior changeclinical practicecognitive performancecognitive testingdisorder preventionexpectationhigh riskimaging modalityneuroethicsoutreachpre-clinicalpreclinical studyprimary outcomepsychologicpsychological distresspsychological outcomespublic health relevanceracial diversityresponserisk variantsocialsocial stigma
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Clinical trials for the prevention of Alzheimer's disease (AD) have been moving to enroll subjects at increasingly early time-points, and are now focusing upon individuals who are cognitively normal, but have biomarkers associated with an increased risk of developing AD. Enriching trials with such biomarkers presents two fundamental concerns that are of critical importance to the future validity and safety of AD trials Will a subject's knowledge of their biomarker status bias the cognitive outcomes of the trial? And will such knowledge cause adverse psychological consequences? In this study, risk communication protocols will be developed and implemented for communicating amyloid PET brain imaging results. Then, 270 cognitively normal individuals (approximately 25% African American), aged 65-80, will be recruited and randomized to receive their amyloid scan results or not, resulting in subjects whose scan results are disclosed or not and subjects whose scans are amyloid positive or not. APOE genotyping with oversampling of e4+ individuals will be used to enrich the enrollment sample, such that roughly half of those scanned will be amyloid positive and half will be amyloid negative. The primary neuropsychological outcome will be the ADCS Preclinical Alzheimer Cognitive Composite (ADCS-PACC) and the primary psychological outcome for psychological distress will be the Impact of Events Scale (IES). The Specific Aims of this study are 1) to determine whether disclosure of elevated brain amyloid will bias ADCS-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) test results; 2) to determine whether disclosure of elevated brain amyloid will cause psychological distress; and 3) to explore how learning amyloid imaging disclosure will impact preventative health behaviors, advance planning for health (e.g. long-term care insurance decisions) and well-being (e.g. stigma, quality of life and relationships).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
-
批准号:10652609
-
项目类别:
-
资助金额:$123.8万
-
财政年份:2021
-
负责人:Robert C. Green
-
依托单位:
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
-
批准号:10442366
-
项目类别:
-
资助金额:$124.51万
-
财政年份:2021
-
负责人:Robert C. Green
-
依托单位:
Experiences and Outcomes in Early Adopters of Predispositional Sequencing
-
批准号:9789918
-
项目类别:
-
资助金额:$76.11万
-
财政年份:2018
-
负责人:Robert C. Green
-
依托单位:
Experiences and Outcomes in Early Adopters of Predispositional Sequencing
-
批准号:9980970
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2018
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8914756
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8826154
-
项目类别:
-
资助金额:$237.06万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8236471
-
项目类别:
-
资助金额:$241.08万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:9173270
-
项目类别:
-
资助金额:$213.26万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8914780
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8586322
-
项目类别:
-
资助金额:$219.54万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Integration of Whole Genome Sequencing into Clinical Medicine
-
批准号:8393216
-
项目类别:
-
资助金额:$220.03万
-
财政年份:2011
-
负责人:Robert C. Green
-
依托单位:
Impact of Direct to Consumer Genetic Testing
-
批准号:7987948
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2010
-
负责人:Robert C. Green
-
依托单位:
Impact of Direct to Consumer Genetic Testing
-
批准号:8147863
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2010
-
负责人:Robert C. Green
-
依托单位:
Impact of Direct to Consumer Genetic Testing
-
批准号:8334094
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2010
-
负责人:Robert C. Green
-
依托单位:
MPC-7869 MEASURE OF COGNITION, ACTIVITIES MILD DEMENTIA OF THE ALZHEIMER'S TYPE
-
批准号:7606297
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE
-
批准号:7606230
-
项目类别:
-
资助金额:$0.69万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
HIGH DOSE SUPPLEMENTS TO REDUCE HOMOCYSTEINE IN ALZHEIMER'S DISEASE
-
批准号:7606235
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
STUDY OF LEUPROLIDE ACETATE DEPOT IN THE TREATMENT OF AD IN MEN
-
批准号:7606250
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
ASSESSMENT MEASURES FOR PRIMARY PREVENTION TRIALS IN ALZHEIMERS DISEASE
-
批准号:7606223
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
AGING AND ALZHEIMER'S DISEASE BIOSAMPLE REPOSITORY
-
批准号:7606237
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2007
-
负责人:Robert C. Green
-
依托单位:
海外基金